Annual review of advances in lung cancer clinical research: A report for the year 2009

Thomas E. Stinchcombe, Jeffrey Bogart, Dennis A. Wigle, Ramaswamy Govindan

Research output: Contribution to journalArticle

15 Scopus citations


The use of positron emission tomography compared with conventional staging increases the detection of extrathoracic metastases and reduces the number futile thoracotomies in patients being evaluated for surgical resection. Long-term follow-up of one of the two adjuvant chemotherapy trials revealed a continued overall survival (OS) benefit to adjuvant chemotherapy. In locally advanced non-small cell lung cancer, a phase III trial of chemoradiotherapy alone and with surgical resection revealed no statistically significant difference in OS between the treatment arms. In advanced stage non-small cell lung cancer, a phase III trial compared gefitinib with carboplatin and paclitaxel in a clinically enriched patient population for epidermal growth factor receptor (EGFR) tyrosine kinase (TK) mutations; among patients with an EGFR TK mutation, patients in gefitinib arm compared with carboplatin and paclitaxel arm experienced a statistically significant superior response rate and progression-free survival, and among patients without EGFR TK mutation patients in the gefitinib arm compared with carboplatin and paclitaxel experienced a statistically significant inferior response rate and progression-free survival. A phase III trial of platinum-based therapy with and without cetuximab in the first-line setting revealed improved OS in the cetuximab arm. A phase III trial of maintenance pemetrexed compared with placebo in patients who had not progressed after initial platinum-based therapy revealed an improvement in OS of patients in the pemetrexed arm with nonsquamous histology. In limited-stage small cell lung cancer, a phase III trial compared standard and high-dose prophylactic cranial irradiation and revealed no significant difference in the rate of brain metastases between the two treatment arms.

Original languageEnglish (US)
Pages (from-to)935-939
Number of pages5
JournalJournal of Thoracic Oncology
Issue number7
StatePublished - Jul 2010



  • Adjuvant chemotherapy
  • Chemoradiotherapy
  • Epidermal growth factor receptor mutations
  • Stereotactic body radiotherapy
  • Surgical resection

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this